Cargando…
Canagliflozin Inhibits Human Endothelial Cell Inflammation through the Induction of Heme Oxygenase-1
Sodium-glucose co-transporter 2 (SGLT2) inhibitors improve cardiovascular outcomes in patients with type 2 diabetes mellitus (T2DM). Studies have also shown that canagliflozin directly acts on endothelial cells (ECs). Since heme oxygenase-1 (HO-1) is an established modulator of EC function, we inves...
Autores principales: | Peyton, Kelly J., Behnammanesh, Ghazaleh, Durante, Giovanna L., Durante, William |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9369341/ https://www.ncbi.nlm.nih.gov/pubmed/35955910 http://dx.doi.org/10.3390/ijms23158777 |
Ejemplares similares
-
Canagliflozin inhibits vascular smooth muscle cell proliferation and migration: Role of heme oxygenase-1
por: Behnammanesh, Ghazaleh, et al.
Publicado: (2020) -
Canagliflozin Inhibits Human Endothelial Cell Proliferation and Tube Formation
por: Behnammanesh, Ghazaleh, et al.
Publicado: (2019) -
Effects of Sodium-Glucose Co-Transporter 2 Inhibitors on Vascular Cell Function and Arterial Remodeling
por: Durante, William, et al.
Publicado: (2021) -
Vasoprotection by heme oxygenase-1: interactions with soluble guanylate cyclase
por: Durante, William
Publicado: (2011) -
Targeting Heme Oxygenase-1 in the Arterial Response to Injury and Disease
por: Durante, William
Publicado: (2020)